E-sisters and the case of the Essure coil: power, representation, and voice in women’s public docket accounts to the FDA of medical device adverse events-Reference-Cited by-同舟云学术

E-sisters and the case of the Essure coil: power, representation, and voice in women’s public docket accounts to the FDA of medical device adverse events

Published:2023-03-15 Issue:5 Volume:51 Page:500-518
ISSN:0090-9882
Container-title:Journal of Applied Communication Research
language:en
Short-container-title:Journal of Applied Communication Research

Author:

Hintz Elizabeth A.¹^ORCID,Applequist Janelle²^ORCID

Affiliation:

1. Department of Communication, University of Connecticut, Storrs, CT, USA

2. Zimmerman School of Advertising and Mass Communications, University of South Florida, Tampa, FL, USA

Publisher

Informa UK Limited

Subject

Language and Linguistics,Communication

Link

https://www.tandfonline.com/doi/pdf/10.1080/00909882.2023.2179417

Reference60 articles.

1. Advocating Safety in Healthcare E-Sisters. (2022). Essure problems. https://www.ashesnonprofit.com/essure

2. Applequist, J. (2016). Broadcast pharmaceutical advertising in the United States: Primetime pill pushers. Lexington Books.

3. Bayer. (2018a). News release: Bayer reaffirms safety profile of Essure. https://www.bayer.com/en/file/35321/download?token=KMNuHS-b

4. Bayer. (2018b). Bayer to voluntarily discontinue U.S. sales of Essure for business reasons. https://www.bayer.com/en/file/35331/download?token=CtHS6hzL

5. Bayer. (2020). Essure permanent birth control. https://www.essure.com/

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA Regulation of Menstrual Devices: Increased Innovation, Decreased Oversight, and Shifting Problems;Women's Reproductive Health;2024-08

2. “Saving us to Death”: Ideology and Communicative (Dis)enfranchisement in Misapplications of the 2016 CDC Opioid Prescribing Guidelines;Health Communication;2024-06-11

3. Indignação, impotência e engajamento. Notas sobre desafios à pesquisa antropológica feminista;Saúde e Sociedade;2023